Advertisement
Departments Letter to the Editor| Volume 96, ISSUE 4, P760, April 2015

Download started.

Ok

Predicting the Response to Botulinum Toxin Treatment in Children With Cerebral Palsy

  • Yu-Ching Lin
    Affiliations
    Department of Physical Medicine and Rehabilitation, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    Medical Device Innovation Center, National Cheng Kung University, Tainan, Taiwan
    Department of Physical Medicine and Rehabilitation, National Cheng Kung University Hospital, Tainan, Taiwan
    Search for articles by this author
Published:January 20, 2015DOI:https://doi.org/10.1016/j.apmr.2014.11.011
      It is interesting to read the article by Bar-On et al.
      • Bar-On L.
      • Campenhout V.
      • Desloovere K.
      • et al.
      Is an instrumented spasticity assessment an improvement over clinical spasticity scales in assessing and predicting the response to integrated botulinum toxin type A treatment in children with cerebral palsy?.
      They compared the responsiveness of clinical and instrumented spasticity assessment for the effects of botulinum toxin type A injection in children with cerebral palsy. However, in the entire article, they used the abbreviated term BTX rather than the distinct trade name for botulinum toxin to denote the medication they injected. I strongly recommend that the authors need to clarify the formulation of botulinum toxin to avoid misunderstanding.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Archives of Physical Medicine and Rehabilitation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bar-On L.
        • Campenhout V.
        • Desloovere K.
        • et al.
        Is an instrumented spasticity assessment an improvement over clinical spasticity scales in assessing and predicting the response to integrated botulinum toxin type A treatment in children with cerebral palsy?.
        Arch Phys Med Rehabil. 2014; 95: 515-523
        • Brin M.F.
        • James C.
        • Maltman J.
        Botulinum toxin type A products are not interchangeable: a review of the evidence.
        Biol Targets Ther. 2014; 8: 227-241
        • Lin Y.C.
        Botulinum toxin injection for post-stroke spasticity.
        Muscle Nerve. 2014; 49: 932
        • Lin Y.C.
        Botulinum toxin type A for management of lateral epicondylitis.
        Can Med Assoc J. 2010; 182 (Accessed October 30, 2014.)
        • Hoare B.
        Rationale for using botulinum toxin A as an adjunct to upper limb rehabilitation in children with cerebral palsy.
        J Child Neurol. 2014; 29: 1066-1076

      Linked Article